NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Networks report the Department of Homeland Security is suspending its frequent flier and quick-processing programs for airport travelers and US border crossings on Sunday.Read More